Article Versions Notes

Coppola PE, Gaibani P, Sartor C, Ambretti S, Lewis RE, Sassi C, Pignatti M, Paolini S, Curti A, Castagnetti F, et al. Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients. Microorganisms. 2020; 8(12):2055. https://doi.org/10.3390/microorganisms8122055

Coppola, Paolo E., Paolo Gaibani, Chiara Sartor, Simone Ambretti, Russell E. Lewis, Claudia Sassi, Marco Pignatti, Stefania Paolini, Antonio Curti, Fausto Castagnetti, and et al. 2020. "Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients" Microorganisms 8, no. 12: 2055. https://doi.org/10.3390/microorganisms8122055

Coppola, P. E., Gaibani, P., Sartor, C., Ambretti, S., Lewis, R. E., Sassi, C., Pignatti, M., Paolini, S., Curti, A., Castagnetti, F., Ursi, M., Cavo, M., & Stanzani, M. (2020). Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients. Microorganisms, 8(12), 2055. https://doi.org/10.3390/microorganisms8122055